These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. The THRIVE score strongly predicts outcomes in patients treated with the Solitaire device in the SWIFT and STAR trials. Flint AC; Cullen SP; Rao VA; Faigeles BS; Pereira VM; Levy EI; Jovin TG; Liebeskind DS; Nogueira RG; Jahan R; Saver JL; Int J Stroke; 2014 Aug; 9(6):698-704. PubMed ID: 24844862 [TBL] [Abstract][Full Text] [Related]
8. Renal impairment reduces the efficacy of thrombolytic therapy in acute ischemic stroke. Power A; Epstein D; Cohen D; Bathula R; Devine J; Kar A; Taube D; Duncan N; Ames D Cerebrovasc Dis; 2013; 35(1):45-52. PubMed ID: 23428996 [TBL] [Abstract][Full Text] [Related]
9. External Validation of the Totaled Health Risks in Vascular Events Score to Predict Functional Outcome and Mortality in Patients Entered into the China National Stroke Registry. Chen W; Liu G; Fang J; Wang Y; Song Y; Pan Y; Li H; Liu L; Wang C; Wang DZ; Zhao X; Wang Y; J Stroke Cerebrovasc Dis; 2016 Oct; 25(10):2331-7. PubMed ID: 27544868 [TBL] [Abstract][Full Text] [Related]
10. The START nomogram for individualized prediction of the probability of unfavorable outcome after intravenous thrombolysis for stroke. Cappellari M; Turcato G; Forlivesi S; Bagante F; Cervellin G; Lippi G; Bonetti B; Bovi P; Toni D Int J Stroke; 2018 Oct; 13(7):700-706. PubMed ID: 29540109 [TBL] [Abstract][Full Text] [Related]
11. External validation of the DRAGON score in an elderly Spanish population: prediction of stroke prognosis after IV thrombolysis. Giralt-Steinhauer E; Rodríguez-Campello A; Cuadrado-Godia E; Ois Á; Jiménez-Conde J; Soriano-Tárraga C; Roquer J Cerebrovasc Dis; 2013; 36(2):110-4. PubMed ID: 24029547 [TBL] [Abstract][Full Text] [Related]
12. Outcome prediction in large vessel occlusion ischemic stroke with or without endovascular stroke treatment: THRIVE-EVT. Flint AC; Chan SL; Edwards NJ; Rao VA; Klingman JG; Nguyen-Huynh MN; Yan B; Mitchell PJ; Davis SM; Campbell BC; Dippel DW; Roos YB; van Zwam WH; Saver JL; Kidwell CS; Hill MD; Goyal M; Demchuk AM; Bracard S; Bendszus M; Donnan GA Int J Stroke; 2023 Mar; 18(3):331-337. PubMed ID: 35319310 [TBL] [Abstract][Full Text] [Related]
13. Posttreatment variables improve outcome prediction after intra-arterial therapy for acute ischemic stroke. Prabhakaran S; Jovin TG; Tayal AH; Hussain MS; Nguyen TN; Sheth KN; Terry JB; Nogueira RG; Horev A; Gandhi D; Wisco D; Glenn BA; Ludwig B; Clemmons PF; Cronin CA; Tian M; Liebeskind D; Zaidat OO; Castonguay AC; Martin C; Mueller-Kronast N; English JD; Linfante I; Malisch TW; Gupta R Cerebrovasc Dis; 2014; 37(5):356-63. PubMed ID: 24942008 [TBL] [Abstract][Full Text] [Related]
14. Predicting outcome of IV thrombolysis-treated ischemic stroke patients: the DRAGON score. Strbian D; Meretoja A; Ahlhelm FJ; Pitkäniemi J; Lyrer P; Kaste M; Engelter S; Tatlisumak T Neurology; 2012 Feb; 78(6):427-32. PubMed ID: 22311929 [TBL] [Abstract][Full Text] [Related]
15. Pre-stroke CHADS2 and CHA2DS2-VASc scores are useful in stratifying three-month outcomes in patients with and without atrial fibrillation. Tu HT; Campbell BC; Meretoja A; Churilov L; Lees KR; Donnan GA; Davis SM Cerebrovasc Dis; 2013; 36(4):273-80. PubMed ID: 24135809 [TBL] [Abstract][Full Text] [Related]
16. Intravenous thrombolysis for acute ischemic stroke associated to extracranial internal carotid artery occlusion: the ICARO-2 study. Paciaroni M; Agnelli G; Caso V; Pieroni A; Bovi P; Cappellari M; Zini A; Nichelli P; Inzitari D; Nesi M; Nencini P; Pezzini A; Padovani A; Tassinari T; Orlandi G; Chiti A; Gialdini G; Alberti A; Venti M; Acciarresi M; D'Amore C; Luda E; Tassi R; Martini G; Ferrarese C; Beretta S; Trentini C; Silvestrelli G; Lanari A; Previdi P; Ciccone A; Delodovici ML; Bono G; Galletti G; Marcheselli S; Del Sette M; Traverso E; Riva M; Silvestrini M; Cerqua R; Consoli D; Monaco S; Toni D Cerebrovasc Dis; 2012; 34(5-6):430-5. PubMed ID: 23207482 [TBL] [Abstract][Full Text] [Related]
17. THRIVE-c score predicts clinical outcomes in Chinese patients after thrombolysis. Pan Y; Peng Y; Chen W; Wang Y; Lin Y; He Y; Wang N; Wang Y Brain Behav; 2018 Feb; 8(2):e00927. PubMed ID: 29484275 [TBL] [Abstract][Full Text] [Related]
18. The effect of time to treatment on outcome in very elderly thrombolysed stroke patients. Frank B; Fulton RL; Lees KR; Int J Stroke; 2014 Jul; 9(5):591-6. PubMed ID: 24588833 [TBL] [Abstract][Full Text] [Related]
19. THRIVE score predicts outcomes with a third-generation endovascular stroke treatment device in the TREVO-2 trial. Flint AC; Xiang B; Gupta R; Nogueira RG; Lutsep HL; Jovin TG; Albers GW; Liebeskind DS; Sanossian N; Smith WS; Stroke; 2013 Dec; 44(12):3370-5. PubMed ID: 24072003 [TBL] [Abstract][Full Text] [Related]
20. Characteristics and outcome of ischemic stroke patients who are free of symptoms at 24 hours following thrombolysis. Strbian D; Sairanen T; Rantanen K; Piironen K; Atula S; Tatlisumak T; Soinne L; Cerebrovasc Dis; 2011; 31(1):37-42. PubMed ID: 20980752 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]